Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for Clostridioides difficile Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective

Introduction: Approximately 3% of hospitalized patients with community-acquired bacterial pneumonia (CABP) develop healthcare-associated Clostridioides difficile infection (HCA-CDI). The validated Davis risk score (DRS) indicates that patients with a DRS ≥ 6 are at an increased risk of 30-day HCA-CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodise, Thomas, Rodriguez, Mauricio, Chitra, Surya, Wright, Kelly, Patel, Nimish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532985/
https://www.ncbi.nlm.nih.gov/pubmed/34680776
http://dx.doi.org/10.3390/antibiotics10101195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532985/
https://www.ncbi.nlm.nih.gov/pubmed/34680776
http://dx.doi.org/10.3390/antibiotics10101195

Ejemplares similares